![](https://investorshub.advfn.com/uicon/430424.png?cb=1554906782)
Friday, December 20, 2013 2:45:23 PM
I keep coming back to this in my head. I listened to the Oppenheimer replay again, and Linda's explanation for the reason it is taking a bit longer to see preliminary results in the direct patients.
Basically, initially, when conducting a phase 1/2 trial like this, they must move "slowly and conservatively" with the first few patients to make certain nothing bad happens.
After that, the enrollment can go at full speed and NWBO states they are literally "mobbed" by people who need therapy and want to enroll.
Think about that for a minute. The entire reason we have not seen the results yet is due to the fact that they are making sure nothing bad happens to the first few patients, but then enrollment will literally be completed immediately after they open the doors to the remaining patients.
Since tumor regression (and not OS or PFS) is the primary endpoint, the events should happen within 8 weeks of treatment. Once that happens, they will move into phase 2 for colorectal cancer. In phase 2, They will not have the initial "slow and conservative" bottleneck they had for phase 1. I think this puts complete enrollment for Direct/phase 2 out to June through July. The results are open, so we will know. If they have phase 3 ready (if the FDA needs a phase 3 at that point).
Think about that. The results from Phase 2 are also open and there will be no initial bottleneck like there was in phase 1.
NWBO can then start phase 3 immediately if the data allow. Will it go back to multiple cancer types in phase 3?
I think it would.
In that case, enrollment would once again be almost instantaneous. Tumor regression would be within weeks. The trial, if it follows the hopeful path, would be stopped early to give all patients treatment.
Could this all happen before the end of 2014? Yes, I think it could, but it all depends on the results from phase 1. If they are near an 80% response rate, than unless L is deemed a success by the board in its first interim, than I think it is feasible they will both be deemed a success at L's second interim. If L is not deemed a success by then, then I think Direct would beat L to the finish line.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM